MEDICSKIN (08307) announced annual performance, with a net profit attributable to shareholders of HKD 936,000, a turnaround from losses to profits year-on-year.
Medis Muscle (08307) released its full-year performance for the year ending March 31, 2026, with revenue of 47.871 million Hong Kong dollars, an increase of 6.13% year-on-year; shareholders' profit amounted to 936,000 Hong Kong dollars, turning from loss to profit year-on-year; basic earnings per share was 0.24 Hong Kong cents.
MEDICSKIN (08307) released its annual performance for the year ending March 31, 2026. The revenue was HK$47.87 million, an increase of 6.13% compared to the previous year. The profit attributable to shareholders was HK$936,000, turning from a loss to a profit. The basic earnings per share was HK$0.24.
Related Articles
Weak demand combined with operational pressures: Lucid (LCID.US) announced a 18% reduction in its US workforce and the elimination of the COO position.
US Stock Market Move | SpaceX (SPCX.US) falls more than 9%, accumulating a 20% drop over three consecutive trading days.
Shenzhen Senior Technology Material (06067): Public offering in Hong Kong receives oversubscription of 1563.16 times.
Weak demand combined with operational pressures: Lucid (LCID.US) announced a 18% reduction in its US workforce and the elimination of the COO position.
US Stock Market Move | SpaceX (SPCX.US) falls more than 9%, accumulating a 20% drop over three consecutive trading days.
Shenzhen Senior Technology Material (06067): Public offering in Hong Kong receives oversubscription of 1563.16 times.
RECOMMEND
